Patent · US Active

Use of gingival fibroblasts for vascular cell therapy

US8609085B2 · kind B2 · utility

3Cited by

1References

18Claims

0Family size

Assignees

UNIVERSITE DE PARIS DESCARTES · FR
L'ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS · FR

Inventors

Antoine Lafont · Paris, FR
Bruno Gogly · Hondevilliers, FR

Key dates

Filing date	Jan 6, 2012
Grant date	Dec 17, 2013
Priority date	—
Expiry date	Jan 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of gingival fibroblasts for obtaining a cellular composition for treating arterial-remodelling pathology, for example an aneurysm, post-cryoplasty stenosis and restenosis, an aortic dissection or atherosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.